base significantly, resulting in a net profit attributable to the Company of Baht 3.59 million (in proportion to the shareholding) for this business of producing and selling dialysis and pharmaceuticals

pharmaceuticals. Consolidated Financial Statement When combining both revenues together, the Group has total revenues of 973.43 million baht, which increased by 10.38 percent from the previous year, and gross

Thailand CH. Karnchang Public Company Limited (the “Company”) hereby reports the connected transaction among the Company and Expert Transport Co., Ltd., whose shares are held by the Company’s major

/2019 Held on November 14, 2019 at 14.00 hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of registered

hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of registered capital total baht 765,000,000 and Paid-up

”) No.9/2019 Held on November 26, 2019 at 13.30 hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of

Company overall. (11) Opinion of the Audit Committee and/or Company’s Directors that is different than the opinion of the Board of Directors : None (12) Opinion of the Independent Expert : None (13

investment with Mr. Akranan Kankittinant (a third person), who is an expert in a major food supplement distribution business in Thailand and such person is not being a connected person of the Company according

production line of flexible packaging and the machine setup process is not complete and new employee lack of expert skill and the use of raw material is inefficient, cause a high production cost. 3. Selling

of the plant and machineries from an independent engineering expert. The effect of such change in the estimated useful lives of assets to the depreciation charge during the quarter is as below; Unit